<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:circular="https://rhnvrm.github.io/stock-market-circulars/ns"><channel><title>544632 - Stock Market Circulars</title><link>https://rhnvrm.github.io/stock-market-circulars/tags/544632/</link><description>Regulatory circulars from NSE, BSE, and SEBI with AI-powered summaries</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Thu, 14 May 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://rhnvrm.github.io/stock-market-circulars/tags/544632/feed.xml" rel="self" type="application/rss+xml"/><item><title>BSE Listing of Further Securities Under ESOP/ESOS - May 15, 2026</title><link>https://rhnvrm.github.io/stock-market-circulars/circulars/bse/2026/bse-2026-05-14-d8821c6d3ae91960-listing-of-further-securities-issued-by-the-companies-under-esop-esos/</link><pubDate>Thu, 14 May 2026 10:56:56 +0000</pubDate><guid>https://rhnvrm.github.io/stock-market-circulars/circulars/bse/2026/bse-2026-05-14-d8821c6d3ae91960-listing-of-further-securities-issued-by-the-companies-under-esop-esos/</guid><description>BSE notifies listing of new securities issued by 10 companies under Employee Stock Option Plans (ESOP/ESOS), effective May 15, 2026. Companies include Amber Enterprises, Cyient, Dr. Lal Pathlabs, Federal Bank, and others.</description><circular:source>bse</circular:source><circular:category>listing</circular:category><circular:impact>medium</circular:impact><circular:severity>low</circular:severity><circular:importance>medium</circular:importance><circular:id>d8821c6d3ae91960</circular:id><circular:pdfUrl>https://www.bseindia.com/downloads/UploadDocs/Notices/20260514-16/20260514-16.pdf</circular:pdfUrl><circular:stock>AMBER</circular:stock><circular:stock>CYIENT</circular:stock><circular:stock>LALPATHLAB</circular:stock><circular:stock>FEDERALBNK</circular:stock><circular:stock>GOKALDAS</circular:stock><circular:stock>MEESHO</circular:stock><circular:stock>NUVAMA</circular:stock><circular:stock>SHRIRAMFIN</circular:stock><circular:stock>SUDARSCHEM</circular:stock><circular:stock>UTIAMC</circular:stock><category>esop</category><category>esos</category><category>listing</category><category>equity</category><category>employee-stock-options</category><category>new-securities</category><category>540902</category><category>532175</category><category>539524</category><category>500469</category><category>532630</category><category>544632</category><category>543988</category><category>511218</category><category>506655</category><category>543238</category><content:encoded><![CDATA[<h2 id="summary">Summary</h2>
<p>BSE has notified trading members that further securities issued by 10 companies under Employee Stock Option Plans (ESOP/ESOS) are listed and admitted for trading effective Friday, May 15, 2026. The newly listed shares span companies across sectors including financial services, healthcare, chemicals, and technology. None of the shares are subject to a lock-in period.</p>
<h2 id="key-points">Key Points</h2>
<ul>
<li>10 companies have had new ESOP/ESOS shares listed for trading from May 15, 2026</li>
<li>All newly listed shares have no lock-in period (NA)</li>
<li>Meesho Limited has the largest allotment with 13,913,282 shares (face value ₹1)</li>
<li>Federal Bank has the second largest allotment with 229,887 shares</li>
<li>Shriram Finance and UTI Asset Management are also among the companies with fresh listings</li>
<li>Notice issued under Listing Operations department, Category: Company Related, Segment: Equity</li>
</ul>
<h2 id="regulatory-changes">Regulatory Changes</h2>
<p>No regulatory changes. This is a routine operational notice under existing ESOP/ESOS listing framework.</p>
<h2 id="compliance-requirements">Compliance Requirements</h2>
<p>Trading members are requested to take note of the newly listed securities and update their systems accordingly to enable trading from May 15, 2026.</p>
<h2 id="important-dates">Important Dates</h2>
<ul>
<li><strong>Notice Date:</strong> May 14, 2026</li>
<li><strong>Effective Date for Trading:</strong> May 15, 2026 (Friday)</li>
</ul>
<h2 id="impact-assessment">Impact Assessment</h2>
<table>
  <thead>
      <tr>
          <th>Company</th>
          <th>Scrip Code</th>
          <th>ISIN</th>
          <th>Shares Listed</th>
          <th>Face Value (₹)</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td>Amber Enterprises India Limited</td>
          <td>540902</td>
          <td>INE371P01015</td>
          <td>28,100</td>
          <td>10</td>
      </tr>
      <tr>
          <td>Cyient Limited</td>
          <td>532175</td>
          <td>INE136B01020</td>
          <td>3,140</td>
          <td>5</td>
      </tr>
      <tr>
          <td>Dr. Lal Pathlabs Limited</td>
          <td>539524</td>
          <td>INE600L01024</td>
          <td>82,750</td>
          <td>10</td>
      </tr>
      <tr>
          <td>Federal Bank Ltd.</td>
          <td>500469</td>
          <td>INE171A01029</td>
          <td>229,887</td>
          <td>2</td>
      </tr>
      <tr>
          <td>Gokaldas Exports Ltd</td>
          <td>532630</td>
          <td>INE887G01027</td>
          <td>3,400</td>
          <td>5</td>
      </tr>
      <tr>
          <td>Meesho Limited</td>
          <td>544632</td>
          <td>INE0VDM01015</td>
          <td>13,913,282</td>
          <td>1</td>
      </tr>
      <tr>
          <td>Nuvama Wealth Management Limited</td>
          <td>543988</td>
          <td>INE531F01023</td>
          <td>138,099</td>
          <td>2</td>
      </tr>
      <tr>
          <td>Shriram Finance Limited</td>
          <td>511218</td>
          <td>INE721A01047</td>
          <td>144,142</td>
          <td>2</td>
      </tr>
      <tr>
          <td>Sudarshan Chemical Indus. Ltd.</td>
          <td>506655</td>
          <td>INE659A01023</td>
          <td>15,640</td>
          <td>2</td>
      </tr>
      <tr>
          <td>UTI Asset Management Company Limited</td>
          <td>543238</td>
          <td>INE094J01016</td>
          <td>1,800</td>
          <td>10</td>
      </tr>
  </tbody>
</table>
<p>The listings represent minor equity dilution for most companies. Meesho&rsquo;s ~13.9 million share ESOP listing is the most significant in volume but given the ₹1 face value and the company&rsquo;s total share base, the dilution impact remains limited. These are standard employee compensation-related listings with no material market disruption expected.</p>
]]></content:encoded></item></channel></rss>